Category: Biopharmaceuticals
Global Biopharmaceuticals
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032 The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market ... Read More
-
Global Bioprocessing Probes and Sensors Market: Focus on Workflow, End User, Type, and Over 12 Countries’ Data - Analysis and Forecast, 2024-2033
... food and beverage, environmental monitoring, and biofuel production. These probes and sensors are integrated into bioprocessing equipment and systems to enable real-time monitoring, control, and optimization of various parameters critical for efficient and high-quality production ... Read More
-
Biologic Therapeutic Drugs: Technologies and Global Markets
... analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2028, as well as key market players. This report details market shares for ... Read More
-
Global Cell Culture Media Market Size Study & Forecast, by Type (Serum-free Media, Classical Media & Salts, Stem Cell Culture Media, Specialty Media, Chemically defined Media, Other Cell Culture Media), by Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Other Applications), by End user, and Regional Analysis, 2023-2030
... Drug Screening & Development, Other Applications), by End user, and Regional Analysis, 2023-2030 Global Cell Culture Media Market is valued at approximately USD 5.34 billion in 2022 and is anticipated to grow with a healthy ... Read More
-
Biopharmaceuticals Contract Manufacturing Global Market Report 2024
... Operations; Analytical And QC studies; Packaging4) By Application: Clinical; CommercialCovering: Boehringer Ingelheim GmbH; Lonza Group Ltd.; Inno Biologics Sdn Bhd; Rentschler Biopharma SE; Samsung Biologics Co. Ltd. Biopharmaceuticals Contract Manufacturing Global Market Report 2024 from ... Read More
-
Insulin biosimilars Global Market Report 2024
... Retail Pharmacies; Online Pharmacies4) By End User: Hospitals; Ambulatory Surgical CentersCovering: Eli Lilly and Company; Boehringer Ingelheim GmbH; Merck & Co Inc.; Pfizer Inc.; Biocon Ltd. Insulin biosimilars Global Market Report 2024 from The Business ... Read More
-
Small-Scale Bioreactors Global Market Report 2024
... Stem Cells; Recombinant Proteins; Vaccines; Gene Therapy4) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs); Academic And Research InstitutesCovering: Sartorius AG; Thermo Fisher Scientific Inc.; Merck KGaA; ... Read More
-
Biobetters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Biobetters Market has demonstrated robust growth from 2024 to 2031. This growth trajectory is set to continue, with an anticipated steady CAGR of 10% expected between 2024 and 2031. In 2024, the global Biobetters Market ... Read More
-
Global Insulin Biosimilars Market - 2023-2030
... period 2023-2030. Biosimilars are equivalent to a reference biologic drug and are developed after the patent on the concerned biologic drug has passed. Biosimilar insulin is a biological replica of an actual insulin and there ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.48 billion in 2024, at a CAGR 9.49% to reach USD 28.49 billion by 2030. Global Biopharmaceutical Bioseparation Systems Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 621.39 million in 2024, at a CAGR 11.71% to reach USD 1,213.54 million by 2030. Global Biopharmaceuticals Manufacturing Consumables Testing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Global Forecast 2024-2030
... USD 81.32 billion in 2023 and expected to reach USD 95.65 billion in 2024, at a CAGR 18.10% to reach USD 260.65 billion by 2030. Global Biopharmaceutical CMO & CRO Market FPNV Positioning Matrix The ... Read More
-
Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 7.82% to reach USD 26.52 billion by 2030. Global Biopharmaceutical Fermentation System Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Global Forecast 2024-2030
... 2023 and expected to reach USD 71.32 billion in 2024, at a CAGR 10.64% to reach USD 131.08 billion by 2030. Drug discovery consists of new medications being discovered by using a vast array of ... Read More
-
Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Global Forecast 2024-2030
... and expected to reach USD 1.59 billion in 2024, at a CAGR 5.61% to reach USD 2.21 billion by 2030. Global Pompe Disease Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Cell Culture Media Market by Product Type (Chemically Defined Media, Classical Media, Lysogeny Broth), Application (Biological Drug Discovery, Biopharmaceuticals, Cancer Research), End-User - Global Forecast 2024-2030
... USD 1.42 billion in 2023 and expected to reach USD 1.61 billion in 2024, at a CAGR 13.53% to reach USD 3.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Ulcerative Colitis Market by Drug (Anti-Inflammatory Drugs, Anti-TNF Biologics, Calcineurin Inhibitors), Disease (Fulminant Colitis, Left-Sided Colitis, Pancolitis or Universal Colitis), Route of Administration - Global Forecast 2024-2030
... USD 7.45 billion in 2023 and expected to reach USD 8.14 billion in 2024, at a CAGR 9.41% to reach USD 13.99 billion by 2030. Global Ulcerative Colitis Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030
... USD 10.70 billion in 2023 and expected to reach USD 12.09 billion in 2024, at a CAGR 13.54% to reach USD 26.03 billion by 2030. Global Upstream Bioprocessing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Global Forecast 2024-2030
... expected to reach USD 3.15 billion in 2024, at a CAGR 5.24% to reach USD 4.30 billion by 2030. Global Spine Biologics MarketSpine biologics refer to a category of medical products and treatments that utilize ... Read More
-
Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Global Forecast 2024-2030
... 6.54 billion in 2023 and expected to reach USD 7.30 billion in 2024, at a CAGR 11.79% to reach USD 14.28 billion by 2030. Global Biologics Contract Development Market FPNV Positioning Matrix The FPNV Positioning ... Read More
Research Assistance
